RenovoRx Ownership | Who Owns RenovoRx?
RenovoRx Ownership Summary
RenovoRx is owned by 5.99% institutional investors, 1.90% insiders, and 92.11% retail investors. Adar1 capital management is the largest institutional shareholder, holding 2.38% of RNXT shares. Fidelity Extended Market Index is the top mutual fund, with 0.59% of its assets in RenovoRx shares.
RNXT Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | RenovoRx | 5.99% | 1.90% | 92.11% |
Sector | Healthcare Stocks | 47.38% | 7.99% | 44.63% |
Industry | Biotech Stocks | 45.43% | 7.81% | 46.75% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Adar1 capital management | 355.24K | 2.38% | $401.42K |
Geode capital management | 143.92K | 0.96% | $162.65K |
Nixon peabody trust | 97.17K | 0.65% | $109.80K |
Millennium management | 86.32K | 0.58% | $97.54K |
Vanguard group | 56.74K | 0.38% | $64.11K |
Charles schwab investment management | 49.23K | 0.33% | $55.63K |
Citadel advisors | 26.20K | 0.18% | $29.60K |
State street | 26.15K | 0.17% | $29.55K |
Affinity capital advisors | 13.28K | 0.09% | $15.01K |
Blackrock | 9.16K | 0.06% | $10.35K |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Adar1 capital management | 355.24K | 0.08% | $401.42K |
Nixon peabody trust | 97.17K | 0.01% | $109.80K |
Affinity capital advisors | 13.28K | 0.00% | $15.01K |
Tower research capital llc (trc) | 7.39K | 0.00% | $8.35K |
Bank of america corp /de/ | 182.00 | - | $206.00 |
Millennium management | 86.32K | - | $97.54K |
State street | 26.15K | - | $29.55K |
Family firm | - | - | - |
Renaissance | - | - | - |
Charles schwab investment management | 49.23K | - | $55.63K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Adar1 capital management | 355.24K | 0.08% | 355.24K |
Millennium management | 86.32K | - | 86.32K |
Geode capital management | 143.92K | - | 76.83K |
Citadel advisors | 26.20K | - | 26.20K |
State street | 26.15K | - | 7.30K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Hrt financial lp | - | - | -11.74K |
Blackrock | 9.16K | - | -11.68K |
Renaissance | - | - | -10.00K |
Family firm | - | - | -1.00K |
Wells fargo & company/mn | - | - | -69.00 |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Adar1 capital management | 355.24K | 0.08% | 355.24K | $401.42K |
Millennium management | 86.32K | - | 86.32K | $97.54K |
Citadel advisors | 26.20K | - | 26.20K | $29.60K |
Ubs group | 1.30K | - | 1.30K | $1.48K |
Sold Out
Holder | Change |
---|---|
Wells fargo & company/mn | -69.00 |
Family firm | -1.00K |
Renaissance | -10.00K |
Hrt financial lp | -11.74K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2024 | 16 | 77.78% | 895,016 | 171.60% | 5 | 63.05% | 11 | 175.00% | 1 | - |
Mar 31, 2024 | 9 | -18.18% | 329,531 | -0.47% | 3 | 32.15% | 4 | -33.33% | 1 | - |
Dec 31, 2023 | 11 | -21.43% | 331,078 | -8.95% | 3 | 26.59% | 6 | -25.00% | 1 | -50.00% |
Sep 30, 2023 | 14 | 55.56% | 363,630 | 48.82% | 3 | 47.23% | 8 | 60.00% | 2 | - |
Jun 30, 2023 | 9 | -25.00% | 244,336 | -88.83% | 2 | 0.46% | 5 | -37.50% | - | -100.00% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Fidelity Extended Market Index | 140.48K | 0.59% | 17.08K |
Vanguard Institutional Extnd Mkt Idx Tr | 56.74K | 0.24% | - |
Schwab Total Stock Market Index | 49.23K | 0.21% | - |
Fidelity Total Market Index | 47.43K | 0.20% | 47.43K |
Fidelity Series Total Market Index | 32.38K | 0.14% | 21.00K |
State St US Extended Mkt Indx NL Cl C | 8.10K | 0.03% | - |
Spartan Extended Market Index Pool E | 5.78K | 0.02% | 496.00 |
NT Ext Equity Mkt Idx Fd - L | 4.92K | 0.02% | - |
Northern Trust Extended Eq Market Idx | 4.92K | 0.02% | - |
Fidelity Nasdaq Composite Index | 3.79K | 0.02% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Jan 26, 2024 | Agah Ramtin | Chief Medical Officer | Buy | $50.00K |
Jan 26, 2024 | Agah Ramtin | Chief Medical Officer | Buy | $50.00K |
Jan 26, 2024 | Spiegel Robert J. | - | Buy | $50.00K |
Jan 26, 2024 | Spiegel Robert J. | - | Buy | $50.00K |
Jan 26, 2024 | Bagai Shaun | Chief Executive Officer | Buy | $50.00K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q4 | - | - |
2024 Q1 | 10 | - |
2023 Q4 | 2 | - |
2023 Q2 | - | - |
2023 Q1 | - | - |
RNXT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools